Cogent Biosciences's total assets for Q4 2024 were $327.90M, a decrease of -14.61% from the previous quarter. COGT total liabilities were $71.61M for the fiscal quarter, a 3.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.